Search

Your search keyword '"Tan SO"' showing total 3,519 results

Search Constraints

Start Over You searched for: Author "Tan SO" Remove constraint Author: "Tan SO" Journal blood Remove constraint Journal: blood
3,519 results on '"Tan SO"'

Search Results

2. Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

3. A single-cell atlas identifies pretreatment features of primary imatinib resistance in chronic myeloid leukemia

4. The role of CD8+ T-cell clones in immune thrombocytopenia

5. NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts

6. Single-cell multiomics reveal the scale of multilayered adaptations enabling CLL relapse during venetoclax therapy

11. Single-cell multiomics reveals increased plasticity, resistant populations, and stem-cell–like blasts in KMT2A-rearranged leukemia

14. Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma

17. Characterization of reverse-engineered anti-PF4 stereotypic antibodies derived from serum of patients with VITT

18. Safety and Efficacy of a-319 (a CD3xCD19 T cell engager) in Patients with Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma

20. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome

21. PHF6 regulates hematopoietic stem and progenitor cells and its loss synergizes with expression of TLX3 to cause leukemia

22. Preliminary Safety and Efficacy of Bgb-11417, a Novel Bcl-2 Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)

23. Antigen escape as a shared mechanism of resistance to BCMA-directed therapies in multiple myeloma

27. A Randomized Placebo Controlled Study of a Plant-Based Dietary Versus Supplement Versus Placebo Intervention in Patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Multiple Myeloma (SMM) - the Nutrition Prevention (NUTRIVENTION-3) Study

28. Worldwide Network for Blood and Marrow Transplantation (WBMT) Global Study on Baseline Characteristics and Clinical Outcomes in NEWLY Diagnosed Multiple Myeloma Patients Undergoing Upfront Autologous STEM Cell Transplantation, a Study Off 61,725 Patients from 629 Centers

29. NX-2127-001, a First-in-Human Trial of NX-2127, a Bruton's Tyrosine Kinase-Targeted Protein Degrader, in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia and B-Cell Malignancies

30. A Pilot Plant Based Dietary Intervention in MGUS and SMM Patients with Elevated BMI Is Feasible and Associated with Improvements in Metabolic and Microbiome Biomarkers of Progression

31. Core binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis

32. Strict tropism for CD71+/CD234+ human reticulocytes limits the zoonotic potential of Plasmodium cynomolgi

35. A Real-World Study to End Tyrosine Kinase Inhibitor in Chronic Myeloid Leukaemia (EnTIC) in Malaysia: One Year Follow-up of Multicenter Study in Malaysia

36. Real World Favourable Experience of Haematopoietic Stem Cell Transplantation during Acute Coronavirus Disease 2019 in a Highly-Vaccinated Asian Population

39. Haploidentical Hematopoietic Cell Transplantation of Ex Vivo Tcrαβ-Depleted Grafts with CD45RA-Depleted Memory T Cell Add-Back Reduces Chronic Graft-Versus-Host Disease and Results in Favourable Gvhd-Relapse Free Survival: 5-Year Follow-up of 107 Patients Treated in a Multicenter Study in Singapore

40. Preliminary Safety and Efficacy of Bgb-11417, a Novel Bcl-2 Inhibitor, in Combination with Azacitidine in Patients with Acute Myeloid Leukemia (AML)

41. Risk Factors and Outcome of COVID-19 Infection in Haematological Patients : A Multicenter Retrospective Analysis in Malaysia

42. Chronic Myeloid Leukemia Failed Second Generation Tyrosine Kinase Inhibitor Patients' Molecular Interrogation Using Next Generation Sequencing

44. The Influence of Genetic Ancestry on Disease Biology in Pediatric T-Cell Acute Lymphoblastic Leukemia

47. Stem Cell Autograft Minimal Residual Disease Negativity Improves Outcomes after Autotransplant for Multiple Myeloma

48. A Phase 2 Trial of Colesevelam for Lenalidomide-Associated Diarrhea

50. TET2-Mediated mRNA and DNA Oxidation in Leukemia Homing and Immune Evasion

Catalog

Books, media, physical & digital resources